$EHVVF News

Last published 5mo ago

5mo agoAIBT EHVVFAIBotics Enters Strategic AI Partnership and Joint Venture with ARYA AI Labs to Advance Next-Generation Deterministic "World Models"GlobeNewswireMIAMI, May 19, 2026 (GLOBE NEWSWIRE) -- AIBotics, Inc. (OTCID: AIBT) ("AIBotics" or the "Company"), a global operator deploying AI-enabled robotics and intelligent automation solutions through strategic partnerships
6mo agoAIBT EHVVFAIBotics Crosses the Line from Concept to Cash Flow as 3DX Industries Commits to PHILL™ ProductionGlobeNewswireMIAMI, April 27, 2026 (GLOBE NEWSWIRE) -- AIBotics, Inc. (OTCID: AIBT) ("AIBotics" or the "Company"), a global operator deploying AI-enabled robotics and intelligent automation solutions through strategic partnerships
9mo agoAIBT EHVVFIsraeli Cannibble Food-Tech and AIBotics Enter Israel with Global Partner KEENON RoboticsGlobeNewswireMIAMI and ROSH HAAYIN, Israel, Jan. 23, 2026 (GLOBE NEWSWIRE) -- AIBotics Inc. (OTC:AIBT), a developer of AI-enhanced service robots and intelligent automation software, today announced a partnership with Cannibble
1y agoAIBT EHVVFKEENON Robotics, Creator of XMAN and One of the World's Global Leaders and Largest Robotic Manufacturers, Signs Partnership Agreement With AiboticsGlobeNewswireMIAMI, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Aibotics, Inc.
4y agoEHVVFEhave, Inc. Launches KetaDASH, Its In-Home Ketamine Therapy In The San Francisco And Sacramento MarketGlobeNewswireKetaDASH will provide ketamine therapy for the treatment of mental health disorders KetaDASH is a managed service organization focused on the psychedelic sector with the mission of helping physicians streamline their practice operations, create new rev
4y agoEHVVFEhave, Inc. Expands Its KetaDASH Brand And Begins Producing Revenue With The Purchase Of California Based Rejuv IVGlobeNewswireMIAMI, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a leading healthcare services and technology company, reaffirms its commitment to shareholders to launch its KetaDASH brand by completing the purchase of 100% of Rejuv IV
4y agoEHVVF TPIAEhave Issues Shareholder Letter and Provides Corporate UpdateGlobeNewswireMIAMI, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, today issued a letter to shareholders from its Chief Executive Officer, Ben Kaplan.
4y agoEHVVF TPIAEhave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. VenturesGlobeNewswireMycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin out 30% MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Eh
5y agoEHVVF2021 Psychedelic Investor Guide ReleasedGlobeNewswireMIAMI, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its wholly owned KetaDASH will be one of the sponsors of the 2021 Psych
5y agoEHVVF KONEFEhave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, FloridaGlobeNewswireMIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has hired KGK Science Inc., a contract research organization (CRO) t
5y agoEHVVFPsychedelic Stock Review Initiates Coverage on Ehave Inc.GlobeNewswireMIAMI, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today the Psychedelic Stock Review has initiated coverage.
5y agoEHVVFEhave Announces Inclusion in the 2021 Psychedelic Investor GuideGlobeNewswireMIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it has been included in the 2021 Psychedelic Investor Guide. T
5y agoEHVVFEhave Appoints Board-Certified Gastroenterologist And Licensed Physician Dr. Rahul Dixit To Its Medical Advisory BoardGlobeNewswireMIAMI, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Rahul Dixit has agreed to join the Company's Medical Advisory Boar
5y agoEHVVFEhave Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live ShortlyGlobeNewswireMIAMI, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today its Ehave Covid Passport will be launched in markets
5y agoEHVVFEhave Files 6-K Disclosing LOI Details For The Acquisition Of Moksha Digital SoftwareGlobeNewswireMIAMI, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today that it has filed a Form 6-K with the SEC disclosing
5y agoEHVVFEhave Accelerates Growth With LOI To Acquire India Based Moksha Digital, A Medical Imaging Software ProviderGlobeNewswireMoksha Digital is the creator of the FDA Cleared CuriePACS (Picture Archival and Communication System) and CurieRIS (Radiological Information System) solutions designed to meet the needs of the Radiologists, the Clinicians and the Surgeons. Moksha Digi
5y agoEHVVFEhave Files 6-K Disclosing Research Project AgreementGlobeNewswireMIAMI, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today that it has filed a Form 6-K with the SEC disclosing
5y agoEHVVFEhave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological Vitals From Vastmindz; Prepares To Run Testing On DashboardGlobeNewswireMIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has licensed AI technology from Vastminz as another tool to bring th
5y agoEHVVFEhave Partners with Globally Recognized University to Target Hallucinogen Persisting Perception Disorder (HPPD)GlobeNewswireMIAMI, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, today announced a partnership with a globally recognized university to gather data and b
5y agoAITX EHVVF FGPHF RSHN+3FMW Media, Inc.'s New to The Street TV Announces its 5 TV Interviews Being Broadcasted On Fox Business Network, Tonight, Monday, August 2, 2021 @ 10:30 PM PT and Tomorrow, Tuesday, August 3, 2021 @ 10:30 PM PTGlobeNewswireNEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- FMW Media's New to The Street TV broadcasting its national syndicated show, TONIGHT, Monday, August 02, 2021 at 10:30 PM PT and Tuesday, Night, August 02, 2021 at 10:30PM PT on Fox Business Network. New
5y agoEHVVFHallucinogen Persisting Perception Disorder (HPPD) Research Initiated By EhaveGlobeNewswireHPPD is a psychiatric disorder characterized by the persisting presence of sensory disturbances, most commonly visual, that resemble those produced by the use of hallucinogenic substances. Ehave believes psychedelics are extremely safe, especially unde
5y agoEHVVF SFORFMW Media, Inc.'s New to The Street TV Announces 4 Interviews Being Broadcasted On Fox Business Network, Tonight, Tuesday, July 27, 2021 @ 10:30 PM PTGlobeNewswireNEW YORK, July 27, 2021 (GLOBE NEWSWIRE) -- FMW Media's "New to The Street" TV broadcasting its national syndicated show, TONIGHT, Tuesday, July 27, 2021 at 10:30 PM PT on Fox Business Network. New To The Street's Tuesday night line-up features th
5y agoEHVVF INKW RRSFF SFIO+1New To The Street / Newsmax TV Announces 7 Interviews for This Weeks' TV Broadcast, Sunday, July 25, 2021, Hour Slot 10-11 AM ETGlobeNewswireNEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- FMW Media's New to The Street / Newsmax TV announces its TV airing of this weeks', Sunday, July 25, 2021, broadcasting line-up of its national syndicated 1- hour show, 10-11AM ET. New to The Street's 203
5y agoEHVVFEhave Releases Additional Information On Partnership With Cutting Edge Data Provider As It Expands CapabilitiesGlobeNewswireMIAMI, July 13, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced a partnership with Health Wizz, a Digital Healthcare IT venture focused on FHI
5y agoEHVVFEhave Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness Launching Ketamine Clinical Trials In MiamiGlobeNewswireMIAMI, July 09, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the Company Ehave has hired an Institutional Review Board (IRB) as it pr
5y agoADIL EHVVFFormer member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory BoardGlobeNewswireMIAMI, July 06, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Bankole A. Johnson has agreed to join the Company's Medical Advisor
5y agoEHVVFEhave, Inc. To Be One Of Four Main Sponsors At The Third Annual Psytech Summit on July 19th and 20th, 2021GlobeNewswireMIAMI, July 02, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it will be one of four sponsors at PsyTech, an upcoming complimentary P
5y agoEHVVFEhave, Inc. Adds Published Child, Adolescent And Adult Psychiatrist To Its Medical Advisory BoardGlobeNewswireMIAMI, July 01, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, continues its ongoing commitment to strengthen and broaden its capabilities as Dr. Mune
5y agoEHVVFHealth Wizz Co-Founder, Dr. Nitin Desai, To Assist And Advise Ehave On Mental Health Analytical PlatformsGlobeNewswireMIAMI, June 29, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc., (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today Dr. Nitin Desai consented to join the Company's Medical Advisory Board.
5y agoCMPS EHVVF FTRPF LKYSF+1"The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling"GlobeNewswireOTCStockReview.com News Commentary ATLANTA, June 16, 2021 (GLOBE NEWSWIRE) -- Jim Cramer discussed psychedelics on his June 15, 2021 program and said, "The science behind using psychedelics to treat mental health disorders and addiction is compellin
5y agoEHVVFDr. Jeffrey Kamlet Internationally Recognized Expert on Cardiac Safety in Ibogaine Treatment Joins Ehave as Chief Medical OfficerGlobeNewswireMIAMI, June 15, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the appointment of Jeffrey D. Kamlet, MD, FASAM, DABAM to the position o
5y agoEHVVFEhave To Release Vaccine Passport As Part Of Its Medical PassportGlobeNewswireMIAMI, June 03, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today its Ehave medical passport will give small businesses
5y agoEHVVFEhave Expands Dashboard Capabilities to Include Decentralized Trials and Virtual StudiesGlobeNewswireMIAMI, June 02, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, today announced the expansion of its Dashboard capabilities to include
5y agoEHVVFEhave KetaDASH Subsidiary Commences Data Collection for Potential Patients and Partnering ClinicsGlobeNewswireMIAMI, May 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its KetaDASH subsidiary has commenced data collection for potential patie
5y agoEHVVFEhave, Inc. Announces Engagement of Legal Counsel to Advise on Launch of KetaDASH in Miami Metro Area and across United States; Ehave Creates Path to Revenue StreamGlobeNewswireMIAMI, April 22, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the Company is ahead of schedule and plans launch its KetaDASH www.keta
5y agoCMPS EHVVF MMEDF MYCOFThe Power of the Platform in Psychedelic MedicineGlobeNewswireATLANTA, April 20, 2021 (GLOBE NEWSWIRE) -- If you had a time machine and could go back to the first day of 2020, you would find that very few people were talking about psychedelics and their potential to save lives. OTC Stock Review introduced a large
5y agoEHVVFEhave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping TechnologyGlobeNewswireMIAMI, April 16, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to...